Авторы

  • Ташматов С.А., Мустафаев Д.Р., Худайберганов З.С., Хамидов С.Ю., Абдурайимов Ф.А.

Ключевые слова:

щитовидная железа, жидкостная цитология, система Бетесда, мутация BRAF V600E, папиллярная карцинома.

Библиографические ссылки

Haugen B.R., Alexander E.K., Bible K.C., et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with a Thyroid Nodule and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133. DOI: 10.1089/thy.2015.0020.

Ali S.Z., Baloch Z.W., Cochand-Priollet B., Schmitt F.C., Vielli P., Clark D.P. The 2023 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2023;33(9):1039-1044. DOI: 10.1089/thy.20 23.0141.

Xing M., Alzahrani A.S., Carson K.A., et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA. 2013;309(14):1493-1501. DOI: 10.1001/ja-ma.2013.3190.

Patel K.N., Angell T.E., Babiarz J., et al. Performance of a Multigene Genomic Classifier in Thyroid Nodules with Indeterminate Cytology: A Prospective Blinded Multicenter Study. JAMA Oncol. 2019;5(2):204-212. DOI: 10.1001/jamaoncol.2018. 4616.

Rossi E.D., Pantanowitz L., Hornick J.L. A worldwide journey of thyroid cancer incidence centred on tumour histology. Lancet Diabetes Endocrinol. 2021;9(4):193-194. DOI: 10.1016/S2213-85 87(21)00049-8.

Nikiforov Y.E., Steward D.L., Robinson-Smith T.M., et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009; 94(6):2092-2098. DOI: 10.1210/jc.2009-0247.